The global AI in oncology market is poised to surge from USD 5.40 billion in 2026 to USD 49.53 billion by 2036, growing at a CAGR of 24.8%, according to a detailed report. This growth is driven by precision medicine and intelligent diagnostic advances. Segmented by component (software, hardware, services), cancer type (breast, lung, prostate, others), and application (diagnostics, treatment planning, drug discovery), the market thrives on AI innovations. North America leads the market, while Asia-Pacific is set for rapid growth. Key players include IBM, Microsoft, and Google. The report offers insights into regional trends, opportunities, and strategic industry developments.
Dublin, May 08, 2026 (GLOBE NEWSWIRE) — The “AI in Oncology Market by Component, Cancer Type, and Application – Global Forecast to 2036” has been added to ResearchAndMarkets.com’s offering.
Global AI in oncology market is expected to reach approximately USD 49.53 billion by 2036 from USD 5.40 billion in 2026, at a CAGR of 24.8% during the forecast period (2026-2036).
The report provides an in-depth analysis of the global AI in oncology market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, The report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.
The major factors driving the growth of the AI in oncology market include the intensifying global focus on precision medicine and the rapid expansion of intelligent diagnostic frameworks across diverse clinical ecosystems. Additionally, the rapid expansion of deep learning algorithms, increasing need for high-performance medical imaging, genomic analysis capabilities, and digital health integration are expected to create significant growth opportunities for players operating in the AI in oncology market.
In 2026, North America dominates the global AI in oncology market with the largest market share, primarily attributed to massive investments in AI research and development and the presence of leading technology innovators in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by aggressive digital transformation initiatives and rapid adoption of AI-driven clinical services in China, India, and Japan. Europe, Latin America, and the Middle East & Africa represent emerging markets with growing healthcare digitalization and increasing adoption of AI-powered oncology solutions.
Market Segmentation
Based on Component
By component, the hardware segment holds the largest market share in 2026, primarily attributed to its essential role in supporting high-performance computing and data storage in hospital environments. These systems provide the computational infrastructure necessary for processing complex medical imaging datasets and enabling real-time diagnostic analysis. However, the software solutions segment is expected to grow at the fastest CAGR during the forecast period, driven by the increasing adoption of AI algorithms for clinical decision support, image analysis automation, and personalized treatment planning. The ability to deliver integrated solutions with proven clinical efficacy makes advanced software platforms highly attractive for healthcare institutions.
Based on Cancer Type
By cancer type, the breast cancer segment holds the largest market share in 2026, primarily due to its efficacy in handling high-volume screening data and providing scalable, predictive results for early intervention. The widespread adoption of mammography screening programs and the availability of large training datasets have accelerated AI algorithm development in this segment. The lung cancer segment is expected to witness significant growth during the forecast period, driven by the need for early detection capabilities, advanced imaging analysis, and treatment optimization. Prostate cancer and other cancer types represent emerging segments with growing adoption of AI-driven diagnostic and therapeutic approaches.
Based on Application
By application, the diagnostics segment holds the largest share of the overall market in 2026, due to its critical role in early cancer detection and clinical decision support. AI-powered diagnostic systems provide enhanced accuracy, reduced false positives, and improved patient outcomes through advanced image analysis and pattern recognition.
